A Multicenter, Open-label Phase 1b Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients with Unresectable or Metastatic BRAFV600-mutant Melanoma
- Wood, Paul (Primary Chief Investigator (PCI))
Project: Research
Project: Research